Credit: EASL via Linkedin

Ali­gos, Ar­bu­tus and oth­ers tout ear­ly he­pati­tis ef­fi­ca­cy da­ta at #EASL24

At this year’s EASL In­ter­na­tion­al Liv­er Con­gress, Vir took cen­ter stage Wednes­day to re­port ear­ly Phase 2 da­ta for its he­pati­tis D …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.